VICTORIA BARAJAS: Open Payments
NPI 1487098935 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 72 payments from 23 companies in 2025. Trend: 2023 $2,502 · 2024 $2,292 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| Ascensia Diabetes Care Us Inc. | 8 | $249 |
| Ascendis Pharma Endocrinology Inc | 5 | $216 |
| Madrigal Pharmaceuticals | 8 | $213 |
| Medtronic, Inc. | 5 | $171 |
| ABBVIE INC. | 8 | $143 |
| Novo Nordisk Inc | 6 | $112 |
| Mannkind Corporation | 5 | $101 |
| Sequel Med Tech, LLC | 1 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
Products named: Yorvipath, REZDIFFRA, INPEN SMART INSULIN DELIVERY SYSTEM, SYNTHROID, AFREZZA, JARDIANCE, TWIIST, UNITHROID.
Industry payments across IN — which companies pay providers there.
